You are visitor 16755
Saturday July 4, 2009




Mission & Values

International Pharmaceutical Academy (IPA) is a progressive Canadian organization dedicated to be the primary provider of Quality Education and Training for the Pharmaceutical, Medical Devices, Biologics, Cosmetics, and Allied Industries.

We present experts from industry, academia and government agencies. Providing the best in educational instruction in short course formats together with carefully orchestrated workshops.

IPA Future Events - (Please click here for a full listing of our events)

Leadership Workshop

August 17th – 18th , 2009 | Toronto, Canada

A Two-Day Comprehensive & Interactive Course, With Workshops On:

An effective leader has the ability to get a group of diverse and talented people working together towards a common goal. Sounds easy in principle, and yet this can be a large challenge for many leaders today.

We have found that great leaders, many of whom have strong personalities, find ways to affect others in a positive way and have a lasting and determining influence on people's performances.

In order to succeed as a talented leader, you need everyone contributing and performing individual duties and responsibilities at a very high level of proficiency.

This one and half a day practical "hands on" Leadership Workshop provides tools and the "how-to's" to confidently lead others more effectively. The program focuses on key areas of leadership success.

The participants learn to:

  • self-assessment
  • Characteristics of today's workforce
  • Skills required to be an effective leader
  • Motivational strategies to address the generational mix
  • Effectively communicate and influence others
  • Manage fluent change
  • Achieve the essentials for continuous growth
  • Build trusting and positive relationships with others
  • Influence growth and change in the organization
  • Improve decision-making abilities
  • Learn ways to effectively see the "big picture"
  • Create and sustain great positive team dynamics through effective coaching and development techniques

 

Critical Documentation Control for Laboratory Operations

August 10-11, 2009 | Toronto, Canada

A One & Half Day Comprehensive and Interactive Workshop On:

  • Understanding GLP Regulatory Expectations for Documentation
  • 21 CFR Part 11 requirements for GLP Documentation
  • FDA Warning Letters
  • Effective Documentation Practices
  • GDP and Change Management
  • Proper Maintenance of Documentary Systems
  • Designing, Writing & Checking Protocols and Reports
  • Effectively Preparing Standard Operating Procedures (SOPs)
  • Policies, Records, Logs, Protocols, Forms, and Work Instruction
  • Management of Raw Data
  • Deviations versus Amendments
  • Preclinical, Clinical and Validation Documentation
  • Protocol Writing and Review
  • Developing and Using Formats & Templates
  • Effective Writing Skills
  • Quality Manuals
  • Reporting and Data Review for Deviations and OOS Results
  • Auditing Sample Documents
Drug Products Stability and Shelf-Life

August 20th - 21st, 2009 | Toronto, Canada

A Two-day Comprehensive and Interactive Course with Workshop on:

  • Critical Elements of Stability Program and Stability Testing
  • FDA, Health Canada, WHO and ICH Guidelines; Q1A, Q1C, Q1D, Q1E, Q1F, Q2A, Q2B, Q3A and Q3B
  • ICH Climate Zones
  • Types of Stability Studies - Stability Study Designs
  • Developmental Stability Studies (i.e., Phase 1 to 3)
  • Consistency Studies for drug submission
  • Validation Studies
  • Routine Stability Studies (Marketed products)
  • Setting-up Stability Program Policies, Procedures, SOPs and Study Protocols
  • Preparation of Stability Reports
  • Consideration in Developing Stability Indicating Methods
  • Designing Reduced Testing Program: Bracketing & Matrixing
  • Rational for Study Duration and Shelf-life Determination
  • Testing Intervals; Long Term and accelerated
  • Study Stability Batch Selection, Sample Size, and Sample Management
  • Stability Chambers: Mapping, Qualification and Monitoring
  • Study Tracking
  • Stability Testing and Evaluation
  • Stability Trending, Failure Investigation; OOS, and OOT
  • Review of Recent Stability Related 483s

Sponsored by:

Sensitech

Environmental Monitoring Program

August 20th, 2009 | Montreal, Quebec, Canada

Featured Topics Include:

  • Regulatory Expectations
  • Non-Sterile Manufacturing
  • Cleanroom classification schemes and Environment
  • Setting up a meaningful Environmental Monitoring plan
  • Microbial Identification
  • Electronic Environmental Monitoring Program
  • Interpretation of results
  • Trend analysis and review of data
  • Preparing EM Summary Reports
Calibration and Qualification in Analytical Laboratories
according to the New USP General Chapter <1058>
“Analytical Instrument Qualification”

August 20th - 21st, 2009 | Somerset, NJ, USA

Highlights of Topics - IQ, OQ, PQ

  • Introduction/Quality Systems
  • Regulatory Requirements and FDA Directives
  • ICH Q7,Q2(R1) and other Guidelines
  • USP <1058> Qualification
  • Measurement Resolution and Errors
  • Calibration Standardization and Validation
  • Calibration Master Doc
  • Calibration Management
  • Laboratory Systems
  • Product Lifecycle Concept
  • Responsibilities of Vendors and Users
    • IQ/OQ/PQ and PM
    • Validation and Qualification Strategies; Risk Assessment Approach
    • ICH Q9/ SO/ASTM guidance
    • Documentation Strategies; Master Validation Plan and Protocols
    • Development of Protocol (Case Study)
    • Examples of OQ and PQ
    • Examples of OQ, PQ: Some Select Protocols
    • HPLC Systems
    • Dissolution Apparatus
    • TOC, LC-MS and others
    • PQ vs. System Suitability
    • Training Requirements
    • Group Exercise

What's new?

Health Canada Informs Pregnant and Breastfeeding Women Not to Take Vitamin Maxum Matragen and/or Maxum Multi Vite Supplements

Health Canada is advising expectant mothers and breastfeeding women not to take the vitamin-mineral supplements Maxum Matragen or Maxum Multi-Vite by Seroyal International Inc. Maxum Multi-Vite has been approved as a vitamin-mineral supplement for only the general public but lacks the required cautionary statement on the label regarding pregnant and/or breast feeding women. The product Maxum Matragen is being promoted by the company as a prenatal supplement; however, neither product has been authorized for sale by Health Canada for use by women who are pregnant or breastfeeding. Read More

A Small Number of Bottles of the Antibiotic Rofact® (Rifampin) May Contain a Different Drug

Health Canada is warning consumers that there is a small possibility that some bottles of one lot of Rofact® (rifampin), an antibiotic used to treat tuberculosis (TB) and some other infections, may contain the drug clonazepam instead of the antibiotic rifampin. The affected lot number of Rofact® is 8K5467, and the Drug Identification Number (DIN) is 00343617. Clonazepam is an anti-epileptic medication and has sedating properties. The manufacturer, Valeant Canada, is initiating a recall to the retail level. Read More

Update - Health Canada Reviewing Hydroxycut Products in light of U.S. Advisory

Health Canada is updating Canadians about Hydroxycut products. On May 1, 2009, the U.S. Food and Drug Administration (FDA) issued a public warning regarding certain Hydroxycut products. The FDA is advising U.S. consumers to stop using Hydroxycut products as there have been reports of liver injuries potentially associated with this product in the United States. Read More

To Submit Your News

 

Copyright © 2009 www.ipacanada.com - International Pharmaceutical Canada - All Rights Reserved.